Dr. Chagin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34th Civic Center Blvd
Childrens Hospital of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-590-2204
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2006 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2002 - 2006
Lewis Katz School of Medicine at Temple UniversityClass of 2002
Certifications & Licensure
PA State Medical License 2006 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers Start of enrollment: 2019 Oct 10
Publications & Presentations
PubMed
- 15 citationsOccurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network.Sumitra Shantakumar, Beth L. Nordstrom, Luc Djoussé, Susan A. Hall, David R. Gagnon
Cancer Chemotherapy and Pharmacology. 2016-07-20 - 138 citationsEltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D. Grainger, Franco Locatelli, Thirachit Chotsampancharoen, Elena K. Donyush, Bunchoo Pongtanakul
Lancet. 2015-10-24 - 119 citationsEltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B. Bussel, Purificación García de Miguel, Jenny M. Despotovic, John D. Grainger, Julián Sevilla
The Lancet. Haematology. 2015-08-01
Industry Relationships
- Medical Director Early Development Oncology, Janssen2014 - Present
- Medical Director, Oncology Research and Development, GSK2009 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
